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1. Introduction 
Abdominal aortic aneurysms (AAAs) are a potentially fatal disorder. Atherosclerotic 
changes followed by accelerated degradation of collagen and elastin, the main components 
of the extracellular matrix (ECM) in the vascular wall, cause the development of AAAs in 
deteriorating aortic walls that dilate progressively and may eventually rupture. Other 
alterations associated with AAAs include marked changes in the cellular composition of the 
aortic wall, especially the infiltration of macrophages and T-lymphocytes into the adventitia 
and a major reduction in the population of vascular smooth muscle cells (SMCs) (Lopez-
Candales et al., 1997; Henderson et al., 1999).  
AAA appear to be a consequence of complex mechanisms involving several potential 
factors: immunological, inflammatory, chemotactic, apoptotic, protease-related, angiogenic 
and fibrinolytic (Ailawadi et al., 2003). Recently, interleukin-8 and monocyte 
chemoattractant protein 1 expression were shown to be raised in the AAA biopsies 
compared to the abdominal aorta of controls, suggesting that pathways involving these 
proteins may be involved in AAA pathologies (Middleton et al., 2009). AAA is a disease 
associated with chronic inflammation in the aortic wall and leukotrienes are powerful lipid 
mediators released by inflammatory cells (Samuelsson, 1983). A recent study showed the 
increased expression of leukotriene C4 synthase together with the predominant formation of 
cysteinyl-leukotrienes in human AAA, linked with matrix metalloproteinases (MMP) 
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production (Di Gennaro et al., 2010). This suggests a mechanism by which leukotrienes may 
promote matrix degradation in the AAA wall. 
Despite reports that major atherosclerotic risk factors are related to AAA (Iribarren et al., 
2007), we still lack the information about the process of aneurysmal degeneration (Wassef et 
al., 2007, Golledge et al., 2008) that we need to develop non-invasive approaches for its early 
detection. In aneurysm formation, collagen degradation exceeds its synthesis and together 
with excessive degradation of other ECM macromolecules, notably elastin, ultimately 
promotes rupture of these aneurysms. Increased local production of proteases, that is, 
enzymes capable of degrading collagen and elastin ECM proteins, have been identified in 
aneurysm sites (Dobrin & Mrkvicka, 1994; Knox et al., 1997; Thompson, 2006). The source of 
these proteases in humans is unclear, however, although many studies have measured their 
expression in cells from biopsies or tissues obtained after surgery (Wilson et al, 2006).  
2. Purpose of the study 
The aim of the study was to conduct a global comparison of the mRNA and protein 
expression profiles in the vascular cells to determine the genes involved in the pathological 
progression of aneurysmal disease by comparing the transcriptomic and proteomic profiles 
of SMCs and macrophages of patients with AAAs and those who have peripheral arterial 
occlusion (PAO) but no AAAs (verified by imaging). Using samples from two groups of 
patients in LILAS (the Lille Anevrysmal Study, described below), those with AAAs and 
others with PAO, we isolated SMCs from aortic tissue and monocytes (that were 
differentiated into macrophages) from blood. Although these diseases have common 
mechanisms, inflammatory cells essentially infiltrate the media and adventitia of the arterial 
wall in AAAs, whereas they are mostly in the intima in PAO. Because the factors that 
influence these distinctions are unknown, we designed a study that would allow us to 
distinguish “pro-aneurysmal” risk factors from those that are associated with atherogenesis 
and stenosis. We choose PAO disease as control diseases as Thompson et al., (Thompson, 
2002) described the separation of AAA disease from other atherosclerotic diseases like 
peripheral vascular disease and carotid disease. 
Following recommendations for large-scale parallel quantitation of proteins (Kingsmore, 
2006), we have constructed a protein microarray that contained on one slide 42 different 
antibodies representing proteins found by transcriptomic and proteomic analysis to be 
differentially modulated in macrophages and SMC from AAA and PAO patients. Finally, we 
performed the same analysis of plasma from the same patients to identify proteins involved in 
the aneurysmal process that are more easily detectable, as hypothesized that circulating 
biomarkers can reflect inflammation and degeneration in the AAA wall (Golledge et al., 2008). 
3. Population study 
The LILle Anevrysmal Study (LILAS) was a case-control study that enrolled 42 men, either 
AAA (case patients) or peripheral arterial occlusion (PAO) (control patients) who needed a 
vascular surgery or endovascular treatment at the Lille University Hospital Centre (Lille, 
France) (Lamblin et al., 2010). The ethics committee of the Lille University Hospital Center 
(France) approved the study (CCPPRB n° CP03/47 of 06 May 2003), and each patient 
provided written informed consent. The protocol required a blood sample (80 ml) to be 
taken at inclusion, before the surgery. All patients underwent the planned surgical 
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treatment and, when possible, surgeons removed the thrombus and took a sample of the 
aneurysm wall in the case patients (n=24) and a sample of the aortic wall during the bypass 
grafting for the control PAO patients (n=18).  
The mean age of subjects was 65.6 ± 6.9 years but AAA patients were older (68.0 ± 6.1 years 
versus 62.3 ± 6.6 years). No other cardiovascular risk factors differed between the groups. In 
both groups, one third of the patients had hypertension and half dyslipidemia. Diabetes 
mellitus was found in 17% of the AAA group and 22% of the PAO group, an insignificant 
difference. Both groups also had similar percentages of family members with a history of 
heart disease (myocardial infarction and/or acute coronary syndrome): 29% in AAA 
patients and 35% in PAO patients. The AAA case patients (n=24) had a mean maximal 
external aortic diameter of 56.1 ± 11.3 [range: 46-95] mm. All the PAO patients had 
undergone recent vascular imaging of the aorta and lower limbs before surgery: none had 
AAAs or iliac, femoral or popliteal aneurysms. The groups did not differ concerning their 
cardiovascular treatment (Table 2, Lamblin et al, 2010). Before surgery, fewer than two 
thirds had antiplatelet treatment. Fewer AAA than PAO patients received ACE inhibitor 
treatment (21% versus 44%). Three of the 18 PAO patients took non-steroidal anti-
inflammatory drugs and no AAA patients.. 
The difference of age between the two groups (AAA and PAO) of patients recruited in this 
study is consistent with literature on the mean age of onset of the disease in patients with 
similar risk factors. Also consistent with the literature is the finding that 30% of AAA 
patients and 50% of PAO patients have family members who have had a myocardial 
infarction or acute coronary syndrome. 
4. Methods 
4.1 Tissue biopsies from AAA and PAO patients 
Aortic samples (Fig. 1) were obtained for 20 of the 24 AAA patients of the LILAS study. 
Because treatment procedures for PAO changed during the study period, from surgical to 
endovascular interventions, tissues were available for only the 4 of the 18 patients who had 
surgical treatment (Fig. 1).  
 
 
Fig. 1. Aneurysmal (AAA) and peripheral arterial occlusion (PAO) tissue used for culture of 
smooth muscle cells and macrophages. Example of biopsy tissue recovered for AAA (n=20) 
and PAO (n=4) patients. 
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4.2 Primary smooth muscle cells cultures 
Human SMCs were obtained from all of the AAA tissue samples (n=20) and only one of the 
four samples from PAO patients. Individual cultures of human aortic SMCs were 
established for each patient by dissection of a residual segment of abdominal aorta and then 
cutting out the media into 1- to 2-mm3 pieces and culturing them on dishes coated with 
collagen type 1. Cells began to migrate from the explant after 10 days and confluence was 
reached in one month.  
4.3 Primary cultures of human monocytes-derived macrophages 
Primary cultures of human macrophages are the cell models used most often in vitro for 
human macrophages, because only a simple venous blood sample is required to investigate 
qualitative or quantitative macrophage modifications in a case-control study. A highly-
standardized primary culture had to be devised to take into account the individual genetic 
variability of each blood donor, as well as the behavioral and environmental influences, and 
hidden abnormalities (Korke et al., 2002). Primary cultures of human macrophages were 
prepared as previously described (Pinet et al., 2003), with a technique adapted from Boyum 
(Boyum, 1968).  
4.4 Transcriptomic analysis of vascular cells from AAA and PAO patients 
Specific oligonucleotides for 137 genes corresponding to 24 matrix metalloproteinases (MMP), 
4 tissue inhibitors of metalloproteinases (TIMP), 20 ADAMs (a disintegrin and 
metalloproteinase), 20 ADAMTS (ADAMS with thrombospondin motifs), 65 other proteases 
and 4 control genes (hydroxymethylbilane synthase, beta-actin, NADPH oxidase 1, and 
Glyceraldehyde-3-phosphate dehydrogenase (GADPH)) were designed with OLIGOMER 
software (Mediagen, France) as previously described (Lamblin et al., 2010). Data were 
analyzed in comparison to a reference RNA, mixture from brain, colon, heart, placenta and 
testis, chosen for the expression of each protease and anti-protease in at least one of these 
tissues. We performed a self (Cy3)-self (Cy5) hybridization of the reference RNA and observed 
equivalent staining throughout the microarray, except for the renin gene which we excluded 
from the analysis (not shown). RNA samples were extracted from human SMCs and 
macrophages and only RNA with a RIN value >9 was analyzed. Each sample (5 µg) was 
analyzed with two slides according to a dye-swap strategy to account for labeling and 
detection differences between Cy5 and Cy3. Data analysis was performed with the statistical 
language R (v 2.0.1) (Ihaka & Gentelman, 1996), more specifically with the LIMMA library 
(Linear Models for MicroArray data) (Smyth et al, 2003). In accordance with the MIAME 
(Minimum Information About a Microarray Experiment) guidelines, we note the steps 
involved in data processing: 1) each microarray was scanned twice (at high and low intensity) 
for each wavelength of Cy3 and Cy5; 2) two separate normalization steps were conducted : 
first, pin-by-pin and second, a lowess fitness normalization. A moderated t-statistic with 
empirical Bayes shrinkage of the standard error was used to classify the statistically significant 
modulations (Lönnstedt & Speed, 2003). Because of multiple testing, p-values were corrected 
(Benjamini & Hochberg, 1995) to control for the false discovery rate. Genes with an adjusted p-
value < 0.01 in at least three of five replications were considered further. 
4.5 Proteomic analysis of vascular cells from AAA and PAO patients 
Intracellular proteins from macrophages and SMCs of AAA and PAO patients were loaded (5 
µg) on 2D gels. 2D-DIGE was performed as recently described (Dupont et al, 2008). Image 
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analysis was performed with Progenesis SameSpots v2.0 software. The differences in protein 
spots were then analyzed. Spots were considered to have significantly different normalized 
spot volumes if the fold change was greater than 1.5 and the corresponding p value (one-way 
ANOVA analysis) was significant. The last step applied multivariate statistics to the selected 
spots by calculating q values (for the false discovery rate) and power. Spots corresponding to 
proteins differentially expressed between the different groups of samples were identified by 
MALDI-TOF following the protocol previously described (Acosta-Martin et al, 2009).  
4.6 Protein microarray profiling of vascular cells and plasma from AAA and PAO 
patients 
The protein arrays allowed us to monitor 42 protein-antibody pairs and detected the profile 
of differentially expressed proteins in aneurysmal disease. Four differentially expressed 
proteins were selected from 2D analysis of macrophages from the LILAS or an earlier study: 
HSP70, aconitase-1, GRP75 and beta-actin (Dupont et al, 2008). Four others were selected 
from microarray analysis, TIMP-3, ADAMTS10, fibronectin, and tenascin. Finally, four more 
were identified by the 2D-analysis of plasma from patients from LILAS (personal 
communications), apolipoprotein AII, vitronectin, transthyretin and factor H. 
5. Results  
Recently, laser microdissection was used to analyze mRNA expression from macrophages 
and SMCs from aneurysmal tissue of a rat model of AAA created using elastase infusion 
(Sho et al., 2005). They found that modulation of at least 5 mRNAs differed according to cell 
type and flow conditions and thus concluded that a global analysis of aneurysmal tissue 
could mask cellular responses specific to inflammation and flow. These recent data reinforce 
our strategy to quantify mRNA and protein expression in two types of vascular cells from 
patients with different pathologies: macrophages and SMCs from AAA and PAO patients, 
instead of analysing the whole AAA or PAO biopsies. 
5.1 Primary smooth muscle cells cultures 
All the cultured human SMCs had the same elongated, spindle-shaped morphology, and at 
confluence all cultures assumed a hill-and-valley pattern that was maintained throughout 
all subcultures (Fig. 2).  
 
 
Fig. 2. Phase-contrast microscopy of smooth muscle cells obtained by explant from human 
AAA (n=20) and PAO (n=4) biopsies. Western blot analysis of SMC for fibronectin, meta-
vinculin (160 kDa), vinculin (116 kDa) and α-smooth muscle actin. 
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Protein expression profiles determined by western blot analysis showed that all the cultures 
from both patient groups, expressed α-smooth muscle actin, vinculin and metavinculin. This 
finding indicates the presence of differentiated SMCs, as well as fibronectin, a component of 
basement membrane, that is indicative of a proliferative and secretory SMC phenotype (Fig. 2). 
5.2 Primary cultures of human monocytes-derived macrophages 
After, 12 days of culture, monocytes are differentiated into macrophages as shown by phase-
contrast microscopy (Fig. 3). 
 
 
Fig. 3. Phase-contrast microscopy of macrophages prepared from blood samples obtained 
from human patients presenting AAA (n=16) and PAO (n=16). 
The quality of macrophage cultures was evaluated by characterization of two markers,  
ECE-1 (Endothelin converting enzyme-1) mRNA and MMP-9 (Matrix metalloproteinase-9). 
ECE-1 mRNA was detected by RT-PCR on total RNA isolated from macrophages and  
MMP-9 activity was determined in culture medium by gelatin zymography (Pinet et al, 
2003). Sixteen primary MDMs cultures, met these criteria and we observed no differences 
between macrophages obtained from AAA or PAO patients (Fig. 3). 
5.3 Transcriptomic analysis of smooth muscle cells and macrophages from AAA and 
PAO patients 
The importance of proteases as mediators of ECM degradation in vascular disease has been 
proved (Wight, 2005), as the role of other proteases and their inhibitors in AAA (Choke et 
al., 2005). Our global analysis on a dedicated array of proteases and anti-proteases was not 
limited by advance theories or hypotheses, precisely because it was intended to generate 
hypotheses. This technology enables more efficient selection of the possible genes involved 
in AAAs, as shown in two studies that used AAA specimens and a cDNA microarray (Tung 
et al., 2001) or quantitative RT-PCR (Higashikata  et al., 2004). 
We tested mRNA from SMCs of 12 different AAA patients and 2 mRNA samples from one 
PAO patient, and we compared them to the reference RNA. For human macrophages, 
mRNA expression ratio of AAA/PAO genes was tested from 4 different AAA patients and 5 
different PAO patients. 
The microarray analysis indicated that three mRNA sample species appeared to be 
significantly modulated with a q value (moderated p-value) <0.01 in SMCs from AAA 
compared with PAO patients: angiotensin converting enzyme (ACE), ADAMTS5 and 
ADAMTS8. In the AAA patients, ACE (AAA/PAO ratio: - 2.8 fold) was down-regulated, 
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and ADAMTS5 (AAA/PAO ratio: 1.2 fold) and ADAMTS8 (AAA/PAO ratio: 1.3 fold) were 
very slightly but significantly up-regulated (Fig. 4A). The graphs of individual mRNA 
expression (AAA/PAO ratio) for these three genes show the variability between patients 
(Fig. 4B).  Of the 137 genes analyzed first by microarrays and then by Q-PCR for selected 
genes, all showed significant and concordant up- or down-regulation of expression levels 
for CML samples. The down-regulation of ACE mRNA in AAA patients is not surprising as 
a recent meta-analysis showed that ACE I/D polymorphisms are associated with a 
significant risk of AAAs (Thompson et al., 2008), especially in patients with hypertension 
(Korcz et al., 2009). Similarly, we found that ADAMTS5 and ADAMTS8 were up-regulated 
in SMC of AAA compared with PAO patients. These two members of the ADAMTS family 
are involved in vascular lesion development and can degrade different proteoglycans 
present in blood vessels (Yao  et al., 1994). 
 
 
Fig. 4. mRNA expression ratio of AAA/PAO genes from human SMC and macrophages. A:  
mRNA expression of genes in human SMCs from AAA (n=12) and PAO (n=1) patients 
determined by microarray analysis (open box) and by real-time RT-PCR (grey box). B: 
Expression ratio as measured by real-time PCR (displayed in log2) of individual patients 
(open circles) and mean values (closed circles). The horizontal line represents an expression 
level identical to that of PAO (log2(ratio)=0). C: mRNA expression ratio of AAA/PAO genes 
in human macrophages from AAA (n=4) and PAO (n=5) patients determined by microarray 
analysis. Data are expressed in log2(ratio). 
Figure 4C shows that the mRNA samples identified as differentially expressed in 
macrophages from AAA and PAO patients are different from those differentially modulated 
in SMCs. Differential modulation was observed in eight macrophage mRNA samples. Two 
were down-regulated in AAA compared with PAO patients: SCARB1 (scavenger receptor 
class B, member 1) AAA/PAO(ratio: 1.8) and BACE2 (beta-site APP-cleaving enzyme 2) 
(AAA/PAO ratio: 1.2). Six were up-regulated in AAA patients: caveolin 1 (AAA/PAO ratio: 
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1.8), ADAMTS10 (AAA/PAO ratio: 1.7), APP (amyloid precursor protein) (AAA/PAO ratio: 
2.3), MMP-27 (AAA/PAO ratio: 2.3), ADAM12 (AAA/PAO ratio: 1.9) and TIMP3 
(AAA/PAO ratio: 2.3). Microarray analysis of macrophages showed the modulation of other 
proteases and anti-proteases, but we were unable to validate these results by RT-PCR 
because of the limited amount of RNA obtained from cultures. Interestingly, TIMP-3, which 
we found to be up-regulated in macrophages from AAA patients, has been shown to be a 
potent inhibitor of ADAMTS5 (Kashiwagi  et al., 2001). Nonetheless, our results are 
consistent with the data reported (Sho et al., 2005) and thus demonstrate the interest of 
analyzing cell-specific compared with tissue-specific responses.  
5.4 Proteomic analysis of smooth muscle cells and macrophages from AAA and PAO 
patients 
Proteins from macrophages and SMCs of AAA and PAO patients were analysed on 2D gels. 
An average image was established from the scanned gels for macrophages (Fig. 5A) and for 
SMC (Fig. 5B) from AAA and PAO patients.  
 
 
Fig. 5. Representative 2D-DIGE gel analysis of proteome of human macrophages (A) and 
smooth muscle cells (B) from LILAS patients. A : Macrophage proteins  (5 µg) labeled with 
either Cy3 or Cy5 from patients presenting AAA (n=10) or PAO (n=12) were analyzed. B : 
SMC proteins  (5 µg) labeled with either Cy3 or Cy5 from patients presenting AAA (n=10) or 
PAO (n=1) were analyzed. Gels were classified according to the presence of AAA or PAO. 
Polypeptidic spots differentially expressed between patients presenting AAA or PAO are 
indicated by a number and identified by this number in Table 1. The positions of Mr are 
indicated on the left and the pI on the bottom of the gels. 
This differential analysis found twenty-one polypeptidic spots with differential abundance 
levels and a statistically reproducible difference over the series of gels. Four spots were up-
regulated (spots 16, 17, 18 and 19) and 17 down-regulated (spots 1, 2, 3, 4, 5, 6, 7, 8, 9; 10, 11, 
12, 13, 14, 15, 18 and 19) in macrophages from AAA compared with PAO patients (Fig. 5A). 
The intensity of each spot was calculated as the mean ± SD and expressed as a percentage of 
normalized volume. The same approach was used for the SMC proteins, although only two 
2D gels were used for the PAO SMCs (Fig. 5B). This differential analysis found seven 
polypeptidic spots with differential abundance levels and a statistically reproducible 
difference over the series of gels. Two spots were up-regulated (spots 2 and 5) and 5 down-
regulated (spots 1, 3, 4, 6, and 7) in SMC from AAA compared with PAO patients.  
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Table 1 summarizes the identity and factor of variation of proteins differentially expressed 
by macrophages and SMCs from AAA and PAO patients. Of the 21 polypeptidic spots 
differentially expressed for macrophages, 17 were identified by mass spectrometry and 
corresponded to 13 non-redundant proteins. Unfortunately, we were unable to identify 
proteins for SMC due to either the low intensity signal on the mass spectrometry or a low 
probability score. 
 
Spot 
number 
Accession
number 
Protein name Protein function 
Mean of normalized value 
of a spot* 
AAA           PAO 
Fold-change 
((AAA vs 
PAO) 
Macrophages 
1  ND  0.005 ± 0.001 0.022 ± 0.008 0.23 
2 P10636 
Microtubule-
associated protein 
tau 
Promotes 
microtubule 
assembly and 
stability 
0.008 ± 0.004 
 
0.047 ± 0.018 0.18 
3 P11142 
Heat shock cognate 
71 kDa protein 
Chaperone 
0.032 ± 0.011 
 
0.078 ± 0.010 
 
0.41 
4  ND  0.012 ± 0.006 0.089 ± 0.025 0.13 
5 
P25705 
ATP synthase 
subunit alpha 
Produces ATP from 
ADP 
0.005 ± 0.002 0.036 ± 0.010 0.14 
6 0.029 ± 0.010 0.063 ± 0.023 0.47 
7 P14618 
Pyruvate kinase 
isozymes M1/M2 
Glycolytic enzyme 0.019 ± 0.010 0.066 ± 0.024 0.29 
8  ND  0.019 ± 0.005 0.090 ± 0.027 0.21 
9 P30101 
Protein disulfide-
isomerase A3 
Catalyzes the 
rearrangement of -
S-S- bonds in 
proteins 
0.080 ± 0.023 0.154 ± 0.055 0.52 
10 P50395 
Rab GDP 
dissociation 
inhibitor beta 
Regulates the 
GDP/GTP 
exchange 
0.072 ± 0.004 0.122 ± 0.016 0.59 
11 P22695 
Cytochrome b-c1 
complex subunit 2
Part of the 
mitochondrial 
respiratory chain 
0.036 ± 0.018 0.095 ± 0.022 0.38 
12 
P09467 
Fructose-1,6-
bisphosphatase 1 
Carbohydrate 
biosynthesis 
0.317 ± 0.077 0.771 ± 0.043 0.41 
13 0.122 ± 0.023 0.284 ± 0.032 0.43 
14 0.036 ± 0.013 0.073 ± 0.016 0.50 
15 P40121 
Macrophage-
capping protein 
locks the barbed 
ends of actin 
filaments 
0.063 ± 0.009 0.109 ± 0.026 0.57 
16 P04406 
Glyceraldehyde-3-
phosphate 
dehydrogenase 
Carbohydrate 
degradation 
0.22 ± 0.051 0.129 ± 0.025 1.71 
17 
18 
P60709 Actin, cytoplasmic 1
Involved in various 
types of cell 
motility 
0.266 ± 0.028 
0.266 ± 0.028 
0.145 ± 0.037 
0.266 ± 0.028 
1.83 
0.26 
18 P25774 Cathepsin S Thiol protease 0.049 ± 0.011 0.031 ± 0.008 1.56 
19 Q06830 Peroxiredoxin-1 
Involved in redox 
regulation of the 
cell 
0.260 ± 0.125 0.082 ± 0.011 3.18 
20  ND  0.246 ± 0.05 0.386 ± 0.028 0.63 
* spot number corresponds to spot indicated in Fig. 5. 
Table 1. Detailed list of proteins differentially expressed between AAA and PAO samples. 
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Of the macrophage proteins identified, three are components of cytoskeleton: microtubule-
associated protein tau (spot 2), beta-actin (spots 17 and 18) and macrophage-capping protein 
(spot 15) and cathepsin S (spot 18), has protease activity. 
This dual transcriptomic and proteomic analysis of vascular cells from AAA and PAO 
patients revealed both the differences and the complementarity of microarray and 2D-
electrophoresis technologies. Proteomic analysis identified only one protease, cathepsin S as 
differentially expressed in macrophages from AAA and PAO patients. This is consistent 
with previous reports showing an increase of cathepsin S activation in the wall of AAAs 
(Abisi et al., 2007; Abdul-Hussein et al., 2007). Still more recently, leukocyte cathepsin S was 
shown to be involved in macrophage apoptosis and increased SMC content and collagen 
deposition (De Nooijer  et al., 2009). Interestingly, of the 13 proteins identified overall, three 
(microtubule-associated protein tau, beta-actin and macrophage-capping protein) are 
components of cytoskeleton, while the others are involved in protein metabolism and stress 
response. Unfortunately, we were unable to identify the SMC proteins corresponding to the 
polypeptidic spots differentially expressed.  
Because of the different size of the proteome and transcriptome, we did not conduct a global 
correlation analysis of proteins and mRNA levels of SMCs and macrophages from these 
patients. Our strategy was to use specific and dedicated tools to identify the modulation of 
proteins and mRNAs in SMC and macrophages from AAA and PAO patients and to apply 
the same technology to their plasma samples. 
5.5 Protein microarray profiling of SMCs, macrophages and plasma from AAA and 
PAO patients 
Because of the limited amount of proteins available from macrophages and SMCs of our 
LILAS study, we used protein antibody array technology that has been shown to provide 
protein information in a systematic, reproducible and high-throughput fashion in several 
diseases (Sanchez-Carbayo  et al., 2006; Weber  et al., 2007). 
The AAA/PAO ratio for each protein modulated is presented in detail in Table 2. 
First, we analysed macrophages and SMCs proteins from LILAS patients. The microarray, 
revealed up-regulation in AAA patients of three macrophage proteins and down-regulation of 
six, as well as up-regulation of six SMC proteins and down-regulation of eight. All the proteins 
up-regulated in macrophages from AAA patients were also up-regulated in their SMCs: 
fibronectin, β-actin, tenascin. Five of six proteins down-regulated in AAA macrophages were 
also down-regulated in their SMCs: TIMP-3, ADAMTS5, HSP70, aconitase, GRP75.  
Plasma analysis, of course, restricted the number of proteins available that could be detected 
as differentially modulated between the two groups. Interestingly, analysis of plasma from 
the LILAS patients showed only five proteins differentially expressed in plasma from AAA 
and PAO patients, three already selected from the macrophage and SMC samples, 
ADAMTS8 (AAA/PAO ratio: 0.9), ADAMTS5 (AAA/PAO ratio: 1.11) and TIMP-3 
(AAA/PAO ratio: 1.15) and two only in plasma: ApoCIII (AAA/PAO ratio: 0.78) and 
alpha1-antitrypsin (AAA/PAO ratio: 0.88).  
Of particular interest, however, is the finding that TIMP-3, ADAMTS5 and ADAMTS8 were 
differentially expressed in proteins from macrophages, SMCs and plasma. ADAMTS8 is 
known to degrade ECM proteoglycans and has the highest specific activity for cleaving 
aggrecan (Porter et al., 2005). Our data are in agreement with a report (Theocharis et al.,  
2001), which showed a decrease in the concentration of versican in human AAA. 
Unfortunately, tools to measure ADAMTS activity need to be developed (Wagstäter et al., 
2008). Interestingly, TIMP-3 was shown to be modulated in the two cell types involved in 
www.intechopen.com
Transcriptomic and Proteomic Profiles of  
Vascular Cells Involved in Human Abdominal Aortic Aneurysm 
 
115 
AAA, SMCs and macrophages and also in the plasma of the same patients, as shown with 
the overexpression of TIMP-3 in AAA tissue compared to aortic occlusive disease but they 
did not measure plasma TIMP-3 levels of the same patients as we did (Carell et al., 2002). 
The availability of TIMP assays allowed us to confirm the increased plasma levels of TIMP-3 
in AAA patients (Lamblin et al., 2010). 
 
Protein name                                            AAA                                      PAO
                                                                                         Mean value ± SD                                       Ratio AAA/PAO 
Macrophages 
TIMP-3 521 ± 430 1409 ± 811 0.35 
ADAMTS5 439 ± 501 1000 ± 633 0.43 
ADAMTS10 611 ± 567 1190 ± 596 0.45 
HSP70 3634 ± 1369 6971 ± 2559 0.55 
GRP75 4909 ± 2331 8505 ± 1862 0.55 
ACO-1 4171 ± 1315 7028 ± 2958 0.60 
Tenascin 27566 ± 7751 16493 ± 3000 1.65 
Fibronectin 29278 ± 6686 15586 ± 3607 1.75 
Beta-actin 43479 ± 13524 23892 ± 6088 1.80 
Smooth muscle cells*
GRP75 6393 ± 1651 5126/8207 0.56/0.56 
ADAMTS5 882 ± 403 1479/1431 0.59/0.59 
TIMP-4 1247 ± 438 1977/2537 0.63/0.51 
HSP70 7180 ± 1700 11358/8906 0.63/0.62 
Transferrin 2895 ±  2153 4868/5076 0.67/0.59 
ACO-1 6782 ± 2088 10076/8089 0.67/0.66 
ApoAII 6009 ± 1392 8419/7622 0.71/0.63 
Vitronectin 25237 ± 2568 31398/33481 0.80/0.71 
Factor H 2339 ± 378 1733/1647 1.35/1.35 
Tenascin 21849 ± 3847 14181/13722 1.54/1.49 
Beta-actin 26599 ± 4899 16672/15917 1.59/1.56 
Prealbumin 15339 ± 1272 16175/13780 1.60/1.57 
ADAMTS8 962 ± 300 599/774 1.61/1.58 
Fibronectin 23910 ± 4485 14154/15035 1.69/1.65 
Plasma 
APOCIII 14867 ± 4892 18964 ± 6046 0.78 
Alpha1-antitrypsin 60718 ± 6815 68871 ± 12632 0.88 
ADAMTS8 2470 ± 523 2754 ± 594 0.90 
ADAMTS5 2176 ± 720 1956 ± 754 1.11 
TIMP-3 2448 ± 653 2132 ± 610 1.15 
Macrophages and SMC analysis were performed respectively from 16 and 14 AAA and 16 and 11 PAO 
samples; Plasma analysis was performed from 24 AAA and 18 PAO samples.* Due to the limited 
number of SMC samples tested, we did not calculated SD for PAO patient and gave the value from 2 
independent experiments performed.  
Table 2. Expression ratio of proteins in macrophages. smooth muscle cells and plasma from 
AAA and PAO patients. 
6. Conclusion  
The limitations of this study are the relatively few tissue specimens allowing study of SMCs 
from PAO patients, because of changes in their treatment strategy (endovascular protheses 
rather than surgery). To our knowledge, this is the first study to combine several global 
analyses to assess the changes in the expression of genes and proteins of vascular cells 
involved in aneurysmal disease. Its strengths include the largest and most detailed view of 
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changes in proteases and anti-proteases expression in patients presenting AAA. The protein 
array techniques confirmed that the differentially expressed proteins could also be detected 
in plasma. We found a restricted number of proteins differentially expressed between AAA 
and PAO patients: TIMP-3, ADAMTS5 and ADAMTS8that differ significantly in plasma of 
AAA patients compared to PAO approach. Combining transcriptomic and proteomic is a 
valid approach to a better understanding of the pathophysiology of AAA but strengthen the 
need to investigate multiple circulating biomarkers.  
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